Programme : Back to Robert-Jan Lamers

A novel ultrasensitive assay for bioanalytical studies with innovative medicines


A novel bioanalytical assay will be presented, which enables the measurement of innovative medicines at ultralow levels in biological fluids and tissues. The assay is up to a factor 1.000 more sensitive than conventional techniques and can be applied in toxicokinetic, pharmacokinetic, microdose and ADME studies in an early stage of drug research and development. The assay is generic and has a short development time and high throughput. It allows working with limited sample volumes and testing of minute amounts of drug compound. The assay enables pharmacokinetic and ADME studies with highly potent compounds and compounds with low bioavailability and short half life. Applications include peptides, proteins, antibodies and conjugates thereof, nanomedicines and oligonucleotides.
Add to favourites

Hosted By
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App
Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
iPhone App
Android App
Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2018